Skip to Content
Interactive Textbook on Clinical Symptom Research Logo


Home Button

Chemotherapy-Related Nausea & Vomiting
Author Bio
Introduction
What Causes Nausea & Vomiting?
Automatic Nervous System
Chemotherapy Induced NV
NV Control
Currently selected section: Issues in Research Design
Case Study 1
Case Study 2
Summary


Chapter 11: Chemotherapy-Related Nausea & Vomiting: Issues in Research Design
        

Assessment

Central to the scientific investigation into the efficacy of approaches for the control of these side effects is the evaluation and quantification of nausea and emesis. Different methods are needed for the assessment of vomiting and of nausea. Vomiting can be measured objectively, within certain limitations, based on the type of measurement used. Nausea is completely subjective and exists only as the patient defines it --- no external frames of reference or alternatives to self report have proven adequate.

  • Direct observation -- Vomiting can be assessed by simply observing the patient and counting the number of vomiting episodes. This was actually done in early antiemetic studies where patients were often hospitalized for cancer chemotherapy treatments. It is no longer done as patient self reports of emesis are typically the new standard. People do not usually have any confusion over whether or not they have thrown up.

  • Self Report--Nausea is a subjective feeling that is individual to each patient and only the patient can report the presence or grade the severity of the nausea. There are two primary methods for assessing nausea:

    • Some type of interval or Likert scale, which relies on descriptive words; and
    • Some variation of a visual analogue scale, which typically uses a 10 cm line marked in increments to illustrate the points between two extremes.

Delayed emesis and delayed nausea are important factors in the assessment of antiemetic effectiveness that are often overlooked. Comparative antiemetic trials should be specifically designed to evaluate these symptoms. They should be accounted for by describing both the day-by-day responses in order to evaluate the pattern of the phenomenon, and the summary experience across the trial.

A patient diary best accomplishes this. We have not had problems with patients completing recordings of their nausea and emesis experience in time periods corresponding to : "morning, afternoon, evening, and night" over a five day period. Patients complain about more frequent recordings or longer time periods of diary recordings; and that reduces compliance. Both approaches are useful in comparing and evaluating the potential relationship(s) between delayed emesis and potential prognostic factors.

There is no place in assessment for measures of "retches" since they cannot be reliably differentiated from dry heaves or gags and, besides, none of the three have anything to do with either nausea or emesis.


      Back to Section